Form 4: Director Christopher Gingras Increases Stake in Modiv
Statement of Changes in Beneficial Ownership
Director Christopher Gingras acquired 29.96 shares of Modiv Industrial, Inc. common stock via a dividend reinvestment plan.
Summary
- Director Christopher Gingras acquired 29.9615 shares of Class C Common Stock.
- The transaction occurred on May 15, 2026, at a price of $18.17 per share.
- The acquisition was executed through a dividend reinvestment plan.
- Following this transaction, the director's total beneficial ownership is 12,938.1256 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative action related to a dividend reinvestment plan rather than an open-market purchase.
Positives
- Director demonstrates continued commitment to the company through dividend reinvestment.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that routine dividend reinvestment by directors is a standard corporate governance practice and generally reflects long-term alignment with shareholder interests rather than a signal of near-term market sentiment.
Comparison to Industry Standards
- Dividend reinvestment plans (DRIPs) are common among REITs and industrial holding companies to encourage long-term equity retention by insiders.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine dividend reinvestment.
Key Dates
| Date | Description |
|---|---|
| 05/15/2026 | Date of the dividend reinvestment transaction and filing date. |
Keywords
Modiv Industrial, MDV, Insider Trading, Form 4, Dividend Reinvestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.